Feigenbaum BA, Stevenson DD, Simon RA. Respiratory Succinate Sensitivity That Does Not Cross-react In An Aspirin Sensitive Asthmatic. Ann Allergy, 1994; 72:94. Feigenbaum BA, Simon RA, Stevenson DD. Aspirin Intolerance. (Letter) Ann Allergy, 1994; 73:455-56.
Feigenbaum BA, Stevenson DD, Simon RA. Lack of Cross-Sensitivity To IV Hydrocortisone in Aspirin-Sensitive Subjects With Asthma. J Allergy Clin Immunol 1994; 93:242.
Feigenbaum BA, Stevenson DD, Simon RA. Hydrocortisone Sodium Succinate Does Not Cross-react With Aspirin in Aspirin Sensitive Asthmatics. J Allergy Clin Immunol 1995; 96:545-8.
Feigenbaum BA. Insect-sting challenges-all risk and no benefit? (Letter) J Allergy Clin Immunol 1995; 96:704-705.Feigenbaum BA, Simon RA. Remission of Steroid Dependent Asthma Following Fundoplication for Publications (continued)Asymptomatic Reflux. J Allergy Clin Immunol, 1995; 95:202.
Feigenbaum BA, Simon RA. A Case of Vocal Cord Dysfunction Mimicking Asthma. Ann Allergy, 1995; 74:92.
Feigenbaum, BA. Self-reported, doctor-diagnosed 'asthma' is not necessarily asthma; 78.9% of these 'asthma' cases were atopic. (Correspondence) J Allergy Clin Immunol 2008;121:1291.
Feigenbaum BA. Fractional exhaled nitric oxide in subjects with atopic asthma: Correct Definitions of the Terms Atopy and Asthma. (Correspondence) Ann Allergy Asthma Immunol 2008; 101; 110.
Miro K, Feigenbaum BA, Mathew A, Weinfeld JN. Successful Oxaliplatin Desensitization After Unsuccessful Infusion Using A Hypersensitivity Protocol. (Abstract) Ann Allergy Asthma Immunol 2010; 105; A27.
Mathew A, Feigenbaum BA, Miro K, Weinfeld JN. Iatrogenic Hypogammaglobulinemia Resembling Common Variable Immunodeficiency. (Abstract) Ann Allergy Asthma Immunol 2010; 105; A101.
Sutaria M, Miro K, Kister I, Herbert J, Mathew A, Feigenbaum BA. Special Considerations for Rapid Drug Desensitization with Natalizumab. (Abstract) J Allergy Clin Immunol, 2011; 127:Supp, AB196.
Mathew A, Ballas M, Gorsky M, Miro K, Feigenbaum BA. Rapid Desensitization Does Not Prevent "Idiosyncratic" Reaction with Fever to Oxaliplatin. (Abstract) J Allergy Clin Immunol, 2011; 127: Supplement, AB195.
Romanos-Sirakis, E, Feigenbaum BA. Immediate Hypersensitivity Reaction and Successful Rapid Desensitization to Rituximab Followed by Serum Sickness in a 4 Year Old. (Abstract) J Allergy Clin Immunol, 2011; 127: Supp, AB198.
Lieberman SM, Jacobs JB, Lebowitz RA, Fitzgerald MB, Crawford J, Feigenbaum BA.Measurement of Mycotoxins in Patients with Chronic Rhinosinusitis. Otolaryngol Head Neck Surg, 2011;145(2): 327–29
Bernard A. Feigenbaum, M.D. is a Voluntary Assistant Clinical Professor at UCSD School of Medicine. He is Board-Certified, and has over twenty years of clinical and teaching experience as an adult and pediatric Allergy & Immunology specialist.
Dr. Feigenbaum has given presentations about Professionalism in Medicine for the American Board of Internal Medicine, and has lectured at Memorial Sloan-Kettering Cancer Center, Columbia University, Hospital for Special Surgery, Hospital for Joint Diseases, NYU Langone Medical Center, and the NYC Department of Health.
Good Morning America, Sirius Radio, CBS News Radio, and The Rachael Ray Show have all featured Dr. Feigenbaum on-the-air as a medical expert on Allergic Diseases and he’s been quoted in the NY Daily News, Los Angeles Times and other print media.
Dr. Feigenbaum is passionate about improving state-of-the-art Allergy & Immunology medical care and is known for his friendly, caring manner, his professionalism, and his teaching skills.
Dr. Feigenbaum has been a Principal Investigator at NYU Langone Medical Center, and recently published a translational study regarding mycotoxins in chronic rhinosinusitis. He has had 15 articles, abstracts and/or letters published regarding aspirin-exacerbated respiratory disease (AERD; Samter’s triad); chemotherapy and monoclonal desensitization; chronic rhinosinusitis; reflux in asthma; bee sting allergy; vocal cord dysfunction; and nitric oxide in asthma. He is a peer reviewer for the Annals of Internal Medicine and the Journal of Allergy & Clinical Immunology and currently serves on several national committees of the American Academy of Allergy, Asthma & Immunology.
His practice specializes in the diagnosis and treatment of adult and pediatric Food Allergies, Drug Allergies and Respiratory Allergies, including: penicillin allergy; anaphylaxis; peanut, tree nut, wheat and soy allergies; allergic rhinitis (hayfever) and asthma; chronic cough; acute and chronic sinusitis; celiac disease/gluten intolerance; eosinophilic esophagitis; and other allergic diseases.
Dr. Feigenbaum is one of the few allergists in California who performs consultations and penicillin allergy testing on hospitalized patients, and who also has clinical experience and publications regarding drug desensitization to aspirin, chemotherapy and monoclonal antibodies.
1989 MD Boston University School of Medicine (Accelerated 6 Year Medical Program. Combined BA/MD 1983 to 1989)
Residency & Fellowship
1989-1992 Internal Medicine Intern and Resident, (Scripps) Mercy Hospital
1992-1993 Chief Resident, (Scripps) Mercy Hospital
1993-1995 Clinical Fellow in Allergy & Immunology, Scripps Clinic
1995, 2003--present American Board of Allergy & Immunology
2010-present California License Registration #G69281
1992-1995 Clinical Instructor of Medicine, University of California, San Diego
1996-1999 Clinical Instructor of Medicine, Yale University School of Medicine
1999-2008 Assistant Clinical Professor of Medicine, Yale University School of Medicine
2005-2007 Clinical Assistant Professor of Medicine, NYU School of Medicine
2007-2016 Clinical Assistant Professor of Medicine & Otolaryngology, NYU School of Medicine
2015-present Voluntary Assistant Clinical Professor, UCSD School of Medicine.
Update 9/01/2020 Hi Everyone, it's Dr Feigenbaum. We're not accepting new patients right now. You could try my colleagues at Scripps Clinic Allergy Carmel Valley. If you're a current patient and need me for something, my cell phone is 858 215 2201.
San Diego Allergy Asthma & Immunology Consultants, Inc.